What is Amgen's cumulative cost basis?

Amgen (AMGN) reported cumulative cost basis of $11.48B in Q1 2026.

How has Amgen's cumulative cost basis changed year-over-year?

Amgen's cumulative cost basis increased by 38.3% year-over-year, from $8.3B to $11.48B.

What is the long-term trend for Amgen's cumulative cost basis?

Over 5 years (2020 to 2025), Amgen's cumulative cost basis has grown at a -2.8% compound annual growth rate (CAGR), from $9.84B to $8.53B.

Amgen AMGN Cumulative Cost Basis

Cumulative Cost Basis at other companies

Regeneron PharmaceuticalsREGN

——

Nektar TherapeuticsNKTR

——

Oruka Therapeutics, Inc.ORKA

——

Rigel PharmaceuticalsRIGL

——

AbbVieABBV

——

Tango TherapeuticsTNGX

——

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$195.44B+34.6%

Enterprise value$252.2B+25.7%

P/E25.1×+3.1×

P/S5.3×+1.1×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's cumulative cost basis?: Amgen (AMGN) reported cumulative cost basis of $11.48B in Q1 2026.
How has Amgen's cumulative cost basis changed year-over-year?: Amgen's cumulative cost basis increased by 38.3% year-over-year, from $8.3B to $11.48B.
What is the long-term trend for Amgen's cumulative cost basis?: Over 5 years (2020 to 2025), Amgen's cumulative cost basis has grown at a -2.8% compound annual growth rate (CAGR), from $9.84B to $8.53B.